These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16251048)

  • 1. [Humoral immune response and in vitro neutralizing antibody assay on co-delivery of protein HPV16L1 virus-like particle with HPV16L1 gene].
    Song JM; Sun XL; Wang YL; Guo JF; Liu TJ; Si LS
    Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):421-4. PubMed ID: 16251048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Neutralizing Antibody Produced in Mice Directly Immunized with Integrated
    Xv Z; Lv J; Jiang J; Wang W; Feng F; Zhang L; Xue X; Li W
    Viral Immunol; 2019 Sep; 32(7):308-317. PubMed ID: 31381497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model.
    Yan X; Wang D; Liang F; Fu L; Guo C
    Hum Vaccin Immunother; 2014; 10(12):3491-8. PubMed ID: 25483698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune response induced by vaccination with pseudotyped rAAV1 expressing HPV16 L1 protein].
    Zhou YB; Li ZL; Zhou L; Sheng W; Ma HT; Zeng Y
    Bing Du Xue Bao; 2008 Jul; 24(4):300-4. PubMed ID: 18780634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.
    Han JE; Wui SR; Park SA; Lee NG; Kim KS; Cho YJ; Kim HJ; Kim HJ
    Vaccine; 2012 Jun; 30(28):4127-34. PubMed ID: 22561312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction and immunological evaluation of recombinant adenovirus containing codon-modified HPV 16 L1 gene].
    Zhou YB; Zhou L; Li ZL; Sheng W; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):18-20. PubMed ID: 18414690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and activity detection of chicken egg yolk IgY antibody against human papillomavirus 16 type L1 main capsid protein].
    Yang J; Zhang MJ; Qiang L; Su BS; Wang YL; Si LS
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):324-7. PubMed ID: 18359682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice.
    Hongli L; Xukui L; Ting L; Wensheng L; Lusheng S; Jin Z
    Hum Vaccin Immunother; 2013 Jan; 9(1):83-9. PubMed ID: 23108357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response induced by recombinant adenovirus combined with recombinant adeno-associated virus type 1 containing HPV16 L1 gene].
    Zhou YB; Li ZL; Zhou L; Sheng W; Ma HT; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):416-8. PubMed ID: 19544631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody.
    Liu DW; Chang JL; Tsao YP; Huang CW; Kuo SW; Chen SL
    Int J Cancer; 2005 Jan; 113(1):93-100. PubMed ID: 15386434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of RG1 epitope into HPV16L1-VLP does not compromise L1-specific immunity.
    Schellenbacher C; Huber B; Skoll M; Shafti-Keramat S; Roden RBS; Kirnbauer R
    Vaccine; 2019 Jun; 37(27):3529-3534. PubMed ID: 31147274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes.
    Thönes N; Müller M
    Virology; 2007 Dec; 369(2):375-88. PubMed ID: 17822733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1.
    Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N
    Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vaccine delivery system on the induction of HPV16L1-specific humoral and cell-mediated immune responses in immunized rhesus macaques.
    Tobery TW; Smith JF; Kuklin N; Skulsky D; Ackerson C; Huang L; Chen L; Cook JC; McClements WL; Jansen KU
    Vaccine; 2003 Mar; 21(13-14):1539-47. PubMed ID: 12615451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles.
    Patel MC; Patkar KK; Basu A; Mohandas KM; Mukhopadhyaya R
    Indian J Med Res; 2009 Sep; 130(3):213-8. PubMed ID: 19901429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immune response to DNA-based HPV16L1 vaccination by costimulatory molecule B7-2.
    Zheng J; Si L; Song J; Sun X; Yu J; Wang Y
    Antiviral Res; 2003 Jun; 59(1):61-5. PubMed ID: 12834862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
    Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
    Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant.
    Oh YK; Sohn T; Park JS; Kang MJ; Choi HG; Kim JA; Kim WK; Ko JJ; Kim CK
    Virology; 2004 Oct; 328(2):266-73. PubMed ID: 15464846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of prophylactic human papillomavirus type 16 L1 capsid protein vaccine delivered by live attenuated Shigella flexneri strain sh42.
    Yang XF; Qu XZ; Wang K; Zheng J; Si LS; Dong XP; Wang YL
    Acta Biochim Biophys Sin (Shanghai); 2005 Nov; 37(11):743-50. PubMed ID: 16270153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.